From October 1, 2023 to December 31, 2023, the company has repurchased 932,000 shares, representing 0.47% for CNY 10.08 million. With this, the company has completed the repurchase of 1,105,000 shares, representing 0.56% for CNY 13.4 million under the buyback announced on August 31, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
15.97 CNY | +0.38% | +10.44% | -26.44% |
1st Jan change | Capi. | |
---|---|---|
-26.44% | 435M | |
+25.83% | 661B | |
+26.86% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+14.75% | 231B | |
+5.20% | 200B | |
-8.75% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- 002940 Stock
- News Zhejiang AngLiKang Pharmaceutical CO.,LTD.
- Tranche Update on Zhejiang AngLiKang Pharmaceutical CO.,LTD.'s Equity Buyback Plan announced on August 31, 2023.